Ken Thorpe
,


Margaret Foti on Cancer Research

Over the past few decades, we have made significant progress against many forms of cancer. Today, there are nearly 14 million cancer survivors living in the United States, 15 percent of whom were diagnosed 20 or more years ago. There have also been more than 1 million fewer cancer deaths since the early 1990s as a result of declining death rates from cancer.

Margaret Foti
,


Gwen Darien on Cancer Research

Perhaps the most compelling, as well as the least understood of the evolving models for cancer research and care is patient-centered research and care. As a cancer survivor and long-time advocate, I am often asked to provide the patient perspective in the various venues where patient-centered issues are discussed.

Gwen Darien
,


Robert Zirkelbach
,


Select a Contributor Response

Conversations:

How do we promote patient-centered cancer research and care in an era of increasing pressure to control healthcare costs?

View All Conversations

 

How do we promote patient-centered cancer research and care in an era of increasing pressure to control healthcare costs?

Test Name
Test Title, Test Company

Read biography×
This is a test modal

Randy Burkholder on Cancer Research

Submitted by Julie on

We are now in an era of incredible scientific progress, where our understanding of the molecular underpinnings of disease enables scientists and researchers to develop treatments that are more targeted and precise in their impact. As highlighted in a blog post by Dr. Raju Kucherlapati from Harvard, oncology is at the leading edge of advances in personalized medicine, offering patients better options that deliver improved health outcomes.

Marcia Kean on Cancer Research

Submitted by Julie on

Much has been written of late about the potentially transformative impact of Big Data – by which people usually mean massive amounts of clinical, genomic, demographic and transactional information that is way too large to handle with traditional information technology.  Such impact seems to be centered, however, on Big IT companies helping Big Provider organizations in ways that are not visible to us, and seem to have no relevance to our lives as patients so far.

Marcia Kean
,


Pages

Subscribe to PhRMA RSS